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OBJECTIVE — Consumption of sugar-sweetened beverages (SSBs), which include soft
drinks, fruit drinks, iced tea, and energy and vitamin water drinks has risen across the globe.
Regular consumption of SSBs has been associated with weight gain and risk of overweight and
obesity, but the role of SSBs in the development of related chronic metabolic diseases, such as
metabolic syndrome and type 2 diabetes, has not been quantitatively reviewed.
RESEARCH DESIGN AND METHODS — We searched the MEDLINE database up to
May 2010 for prospective cohort studies of SSB intake and risk of metabolic syndrome and type
2diabetes.Weidentiﬁed11studies(threeformetabolicsyndromeandeightfortype2diabetes)
for inclusion in a random-effects meta-analysis comparing SSB intake in the highest to lowest
quantiles in relation to risk of metabolic syndrome and type 2 diabetes.
RESULTS — Based on data from these studies, including 310,819 participants and 15,043
cases of type 2 diabetes, individuals in the highest quantile of SSB intake (most often 1–2
servings/day) had a 26% greater risk of developing type 2 diabetes than those in the lowest
quantile (none or 1 serving/month) (relative risk [RR] 1.26 [95% CI 1.12–1.41]). Among
studies evaluating metabolic syndrome, including 19,431 participants and 5,803 cases, the
pooled RR was 1.20 [1.02–1.42].
CONCLUSIONS — In addition to weight gain, higher consumption of SSBs is associated
with development of metabolic syndrome and type 2 diabetes. These data provide empirical
evidencethatintakeofSSBsshouldbelimitedtoreduceobesity-relatedriskofchronicmetabolic
diseases.
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I
n recent decades, consumption of sug-
ar-sweetened beverages (SSBs), which
include the full spectrum of soft drinks
(soda), fruit drinks, and energy and vita-
min water drinks has been steadily in-
creasing to various degrees across the
globe. For example, in the U.S. between
the late 1970s and 2006 the per capita
consumptionofSSBsincreasedfrom64.4
to141.7kcal/day,representingmorethan
a twofold increase (1). Similar temporal
patterns have been shown for Mexico,
where currently 12% of total energy in-
takeiscontributedbythesebeverages(2).
Of particular concern is the rapid trajec-
tory of increase evident in many develop-
ing countries where access to SSBs has
grown concomitantly with rising rates of
urbanization. Sales ﬁgures from Coca Co-
la’s 2007 annual report show that during
2007, India and China experienced
growths of 14 and 18%, respectively, in
the volume of beverages sold, indicative
ofsubstantialincreasesinsalesatthepop-
ulation level (3).
SSBs, which are now the primary
sourceofaddedsugarsintheU.S.diet,are
composed of energy-containing sweeten-
ers such as sucrose, high-fructose corn
syrup, or fruit juice concentrates, all of
which have essentially similar metabolic
effects (4). In contrast, a beverage that is
100% fruit juice and not blended with
added sweeteners is not considered an
SSB. Increasingly, groups of scholars and
organizations such as the American Heart
Association are calling for major reduc-
tions in consumption of SSBs (5,6). Find-
ings from well-powered prospective
epidemiological studies have shown con-
sistent positive associations between SSB
intake and weight gain and obesity in
both children and adults (7). Emerging
evidence also suggests that habitual SSB
consumption is associated with increased
risk of metabolic syndrome and type 2
diabetes (8). SSBs are thought to lead to
weight gain by virtue of their high sugar
contentandincompletecompensationfor
total energy at subsequent meals after in-
take of liquid calories (7). Because of the
high content of rapidly absorbable carbo-
hydrates such as sucrose (50% glucose
and50%fructose)andhigh-fructosecorn
syrup (most often 45% glucose and 55%
fructose), in conjunction with the large
volumes consumed, SSBs may increase
theriskofmetabolicsyndromeandtype2
diabetesnotonlythroughobesitybutalso
by increasing dietary glycemic load, lead-
ing to insulin resistance, -cell dysfunc-
tion, and inﬂammation (9). Additional
metabolic effects of these beverages may
alsoleadtohypertensionandpromoteac-
cumulation of visceral adipose tissue and
of ectopic fat due to elevated hepatic de
novolipogenesis(10),resultinginthede-
velopment of high triglycerides and low
HDL cholesterol and small, dense LDL,
although the speciﬁc metabolic effects of
fructose versus glucose remain to be fur-
ther examined. To summarize the avail-
able literature, we conducted a meta-
analysis of prospective cohort studies to
examine the relationship between SSB
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Ref. Population (cases)
Age range
(years)
Duration
(years)
Dietary
assessment
method Outcome Results
Adjustment for potential
confounders
Montonen et al.,
2007 (14)
2,360 adults, Finnish
Mobile Clinic
Health
Examination,
Finland (177)
40–69 12 Diet
history
Type 2
diabetes*
RR (95% CI) between
extreme quartiles of
median SSB intake (0 vs.
143 g/day): 1.67 (0.98–
2.87); Ptrend  0.01
Age, sex, BMI, energy intake,
smoking, geographic area,
physical activity, family
history of diabetes,
prudent dietary score, and
conservative pattern score
Paynter et al.,
2006 (15)
12,204 adults ARIC
study, U.S. (718
men, 719 women)
45–64 9 FFQ Type 2
diabetes†
Men: RR (95% CI) between
extreme quartiles of SSB
intake (1 8-oz serving/
day vs. 2 8-oz
servings/day): 1.09
(0.89–1.33); Ptrend 
0.68. Women: RR (95%
CI) between extreme
quintiles of SSB intake:
1.17 (0.94–1.46);
Ptrend  0.05
Race, age
Schulze et al.,
2004 (16)
91,249 women NHS
II, U.S. (741)
24–44 8 133-item
FFQ
Type 2
diabetes†
RR (95% CI) between
extreme quartiles of SSB
intake (1
serving/month vs. 1
serving/day: 1.83 (1.42,
2.36); Ptrend  0.001
Age, alcohol intake, physical
activity, family history of
diabetes, smoking,
postmenopausal hormone
use, oral contraceptive
use, cereal ﬁber,
magnesium, trans fat, ratio
of polyunsaturated to
saturated fat, diet soft
drinks, fruit juice, fruit
punch
Palmer et al.,
2008 (17)
43,960 women
BWHS, U.S.
(2,713)
21–69 10 68-item
FFQ
Type 2
diabetes§
RR (95% CI) between
extreme quintiles of SSB
intake (1 12-oz
serving/month vs.  2
12-oz servings/day: 1.24
(1.06–1.45); Ptrend 
0.002
Age, family history of
diabetes, physical activity,
smoking, education, fruit
drinks, orange and
grapefruit juice, fortiﬁed
fruit drinks, Kool-Aid,
other fruit juices, red
meat, processed meat,
cereal ﬁber, coffee and
glycemic index
Bazzano et al.,
2008 (18);
author
correspondence
71,346 women NHS,
U.S. (4,529)
38–63 18 FFQ Type 2
diabetes‡
RR (95% CI) between
extreme quintiles of SSB
intake: (1 12-oz
serving/month vs. 2–3
12-oz servings/day):
1.31 (0.99–1.74);
Ptrend  0.001
BMI, physical activity, family
history of diabetes,
postmenopausal hormone
use, alcohol use, smoking,
and total energy intake
Odegaard et al.,
2010 (19)
43,580 adults,
Singapore Chinese
Health study
(2,273)
45–74 5.7 FFQ Type 2
diabetes‡
RR (95% CI) between
extreme quintiles of SSB
intake: (none vs. 2
8-oz servings/week):
1.42 (1.25–1.62);
Ptrend  0.0001
Age, sex, dialect, year of
interview, educational
level, smoking, alcohol,
physical activity, saturated
fat, dietary ﬁber, dairy,
juice, coffee
De Koning, 2010,
personal
communication
41,109 male health
professionals, U.S.
(2,760)
40–75 20 FFQ Type 2
diabetes†
RR (95% CI) between
extreme quartiles of
median SSB intake (0 vs.
0.79 serving/day): 1.14
(1.03–1.28); Ptrend 
0.0024
Age, smoking, physical
activity, alcohol, coffee,
family history of type 2
diabetes
(continued)
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abolic syndrome and type 2 diabetes.
RESEARCH DESIGN AND
METHODS
Literature search
Relevant English-language articles were
identiﬁed by searching the MEDLINE da-
tabase (National Library of Medicine, Be-
thesda, MD) from 1966 to May 2010 for
prospective cohort studies of intake of
SSBs (soft drinks, carbonated soft drinks,
fruitades, fruit drinks, sports drinks, en-
ergyandvitaminwaterdrinks,sweetened
iced tea, punch, cordials, squashes, and
lemonade) and risk of metabolic syn-
drome and type 2 diabetes in adults. Key
words such as “soda,” “soda-pop,” and
“sugar-sweetened beverage” combined
with “diabetes,” “type 2 diabetes,” and
“metabolic syndrome” were used in the
primary search strategy and in a subse-
quent medical subheading (MESH) terms
search. Because of the high potential for
intractable confounding and reverse cau-
sation, cross-sectional studies were ex-
cluded. We did not consider short-term
experimental studies because they are not
well-suitedtocapturelong-termpatterns,
but rather provide important insight into
potential underlying biological mecha-
nisms. Our literature search identiﬁed 15
studies with metabolic syndrome as an
end point and 136 studies with type 2
diabetes as an end point. An additional
studyoftype2diabetesbydeKoningand
colleagues was identiﬁed via personal
communication.
Inclusion criteria and data
extraction
The criteria for inclusion of studies in our
meta-analysis included prospective co-
hort design, end points of metabolic syn-
drome or type 2 diabetes, presentation of
a relative risk (RR) and associated mea-
sure of variance (SE or 95% CI), deﬁni-
tion, and metric for SSB intake and
description of adjustment for potential
confounders. After application of these
criteria, three studies of metabolic syn-
drome(11–13)andeightstudiesoftype2
diabetes (11,14–19) were retained for
our meta-analysis. Coefﬁcients and SEs
were obtained from Nettleton et al. (11)
and Bazzano et al. (18) via correspon-
dence.Dataextractionwasindependently
performed by V.S.M. and F.B.H., and
there were no differences in extracted in-
formation to yield effect estimates com-
paring extreme quantiles of intake, most
often comparing none or 1 serving/
month with 1 or 2 servings/day. Nota-
ble exceptions include Odegaard et al.
(19) in which the highest category of in-
Table 1—Continued
Ref. Population (cases)
Age range
(years)
Duration
(years)
Dietary
assessment
method Outcome Results
Adjustment for potential
confounders
Nettleton et al.,
2009 (11);
author
correspondence
5,011 adults, MESA,
U.S. (413)
45–84 5 FFQ Type 2
diabetes
RR (95% CI) between
extreme quartiles of SSB
intake (0 vs. 1 serving/
day): 0.86 (0.62–1.17);
Ptrend  0.09
Study site, age, sex, race,
energy intake, education,
physical activity, smoking,
at least weekly
supplement use, waist
circumference
Nettleton et al.,
2009 (11);
author
correspondence
3,878 adults, MESA,
U.S. (871)
45–84 5 FFQ Metabolic
syndrome¶
RR (95% CI) between
extreme quartiles of SSB
intake (0 vs.  1
serving/day): 1.15
(0.92–1.42); Ptrend 
0.65
Study site, age, sex, race,
energy intake, education,
physical activity, smoking,
at least weekly
supplement use, waist
circumference
Dhingra et al.,
2007 (13)
6,039 adults,
Framingham
Offspring Study,
U.S.A. (1,150)
52.9 4 FFQ Metabolic
syndrome#
RR (95% CI) between
extreme quartiles of soft
drink intake (0 vs. 1
12-oz serving/day): 1.39
(1.21–1.59)**
Age and sex
Lutsey et al., 2008
(12)
9,514 adults ARIC,
U.S. (3,782)
45–64 9 66-item
FFQ
Metabolic
syndrome¶
RR (95% CI) between
extreme tertiles of SSB
intake (0 vs. 1 median
serving/day): 1.09
(0.99–1.19); Ptrend 
0.07
Age, sex, race, education,
center, total calories,
smoking, physical activity,
intake of meat, dairy,
fruits and vegetables,
whole grains, and reﬁned
grains
ARIC, Atherosclerosis Risk in Communities Study; BWHS, Black Women’s Health Study; MESA, Multi-Ethnic Study of Atherosclerosis; NHS, Nurses’ Health Study.
*National register conﬁrmed by medical record. †Presence of one of the following: 1) fasting glucose 126 mg/dl, 2) nonfasting glucose 200 mg/dl, 3) current use
of hypoglycemic medication, and 4) self-report physician diagnosis. ‡Self-report of physician diagnosis and supplemental questionnaire. §Conﬁrmed self-report of
physician diagnosis. Presence of one of the following: 1) fasting glucose 126 mg/dl, 2) current use of hypoglycemic medications; and 3) self-report physician
diagnosis. ¶Metabolic syndrome diagnosed according to the modiﬁed National Cholesterol Education Program Adult Treatment Panel III criteria/American Heart
Association guidelines as the presence of three or more of the following: 1) waist circumference 102 (men) or 88 cm (women), 2) triglycerides 150 mg/dl, 3)
HDL cholesterol 40 (men) or 50 mg/dl (women), 4) blood pressure 130/85 mmHg or antihypertensive treatment, and 5) fasting glucose 100 mg/dl or
antihyperglycemictreatment/insulin.#MetabolicsyndromediagnosedaccordingtothemodiﬁedNationalCholesterolEducationProgramAdultTreatmentPanelIII
deﬁnition/American Heart Association guidelines as the presence of three or more of the following: 1) waist circumference 102 (men) or 88 cm (women), 2)
triglycerides 150 mg/dl, 3) HDL cholesterol 40 (men) or 50 mg/dl (women), 4) blood pressure 135/85 mmHg or antihypertensive treatment, and 5) fasting
glucose 100 mg/dl or antihyperglycemic treatment/insulin. **Includes diet and nondiet soft drinks.
Malik and Associates
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tonen et al. (14) in which the comparison
between median intakes of the ﬁrst and
fourthquartileswas0vs.143g/day(note:
one 12-oz serving  336 g), and Paynter
et al. (15) in which 1 8-oz serving/day
was the reference category. Unless other-
wise speciﬁed a standard serving size of
12 oz was the metric used.
Analysis
A total of eight studies with nine data
pointswereincludedinourmeta-analysis
of type 2 diabetes (11,14–19) and three
studies were included in our meta-
analysis of metabolic syndrome (11–13).
STATA (version 9.0; StataCorp, College
Station, TX) was used to obtain summary
RRs using both random- and ﬁxed-effects
models calculated from the logarithm of
the RRs and corresponding 95% CIs of
the individual studies. We primarily used
a random-effects model because it incor-
porates both a within-study and an addi-
tive between-studies component of
variance, is the accepted method to use in
the presence of between-study heteroge-
neity, and is generally considered the
more conservative method (20). Signiﬁ-
cance of heterogeneity of study results
was evaluated using the Cochrane Q test,
which has somewhat limited sensitivity,
and further by the I
2 statistic, which rep-
resents the percentage of total variation
across studies that is due to between-
study heterogeneity (21). Because adjust-
ment for total energy intake and duration
of follow-up could be important sources
of heterogeneity, we conducted indepen-
dent meta-regressions using adjustment
for energy and study duration as predic-
tors of effect. Because the association be-
tween SSB consumption and these
outcomes is likely to be mediated in part
by an increase in overall energy intake or
adiposity,adjustingforthesefactorsisex-
pected to attenuate the effect. Where pos-
sible we used estimates that were not
adjusted for energy intake or adiposity
and conducted sensitivity analysis by re-
moving studies that only provided ener-
gy- or adiposity-adjusted estimates. The
potential for publication bias was evalu-
atedusingBeggandEggertestsandvisual
inspection of the Begg funnel plot
(22,23).
RESULTS— Characteristics of the
prospective cohort studies included in
our meta-analyses are shown in Table 1.
Three studies evaluated risk of metabolic
syndrome (11–13) and eight studies
(nine data points) evaluated risk of type 2
diabetes (11,14–19). The cohorts in-
cludedmenandwomenofpredominately
white or black populations from the U.S.,
adults from Finland, and Chinese adults
from Singapore, with duration of fol-
low-up ranging from 4 to 20 years and
number of participants ranging from
3,000 to 91,000. The majority of
studies used food frequency question-
naires (FFQs) to evaluate dietary intake
and six studies (seven data points) (13,
15–17, 19) provided effect estimates that
werenotadjustedfortotalenergyormea-
sures of adiposity. Based on data from
these studies, including 310,819 partici-
pantsand15,043casesoftype2diabetes,
the pooled RR for type 2 diabetes was
1.26 (95% CI 1.12–1.41) comparing ex-
treme quantiles of SSB intake, illustrating
an excess risk of 26% associated with
higher consumption of SSB compared
with lower consumption (Fig. 1A).
Amongthreestudiesevaluatingmetabolic
syndrome including 19,431 participants
and 5,803 cases, the pooled RR was 1.20
(1.02–1.42) (Fig. 1B). Pooled RR esti-
mates from the ﬁxed-effects model were
1.25 (1.17–1.32) and 1.17 (1.09–1.26)
for type 2 diabetes and metabolic syn-
drome, respectively. Results from a dose-
responsemeta-analysisfortype2diabetes
riskperincreasein112-ozservingofSSB/
day were RR 1.25 (95% CI 1.10–1.42)
from the random-effects model and RR
1.15 (95% CI 1.11–1.20) from the ﬁxed-
effects model (not shown).
Although all studies except one (11)
showed positive associations, there was
signiﬁcant heterogeneity among studies
Figure 1—A: Forrest plot of studies evaluating SSB consumption and risk of type 2 diabetes,
comparing extreme quantiles of intake. Random-effects estimate (DerSimonian and Laird
method). *Information from personal communication. B: Forrest plot of studies evaluating SSB
consumption and risk of metabolic syndrome comparing extreme quantiles of intake. Random-
effects estimate (DerSimonian and Laird method).
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2
66% [95% CI 31–83%], P value, test for
homogeneity 0.003; for metabolic syn-
drome: 76% [22–93%]; P value, test for
homogeneity 0.01). In general, larger
studies with longer durations of fol-
low-up tended to show stronger associa-
tions. Among studies evaluating type 2
diabetes,theonebyNettletonetal.(11)is
both the shortest and among the smallest,
and the only one to show an inverse al-
though nonsigniﬁcant association (11).
Removal of this study from our analysis
only reduced heterogeneity slightly (I
2
62% [95% CI 17–82%], P value, test for
homogeneity 0.01). In contrast, studies
by Schulze et al. (16) and Palmer et al.
(17), which are longer and larger, show
clearly signiﬁcant positive associations.
Despite this, results from a meta-
regression did not ﬁnd duration of study
to be a signiﬁcant predictor of effect (P 
0.84). The study by Montonen et al. (14),
which shows a borderline signiﬁcant pos-
itiveassociation,hasthefewestnumberof
participantsandconsiderablylowerlevels
of intake relative to those of other studies
(median intake of SSB is 143 g/day in
highest quartile of intake, where one
12-oz serving is 336 g). Removal of this
study from our analysis did not reduce
heterogeneity, which is to be expected,
givenitssmallpercentageweight(Pvalue,
testforhomogeneity0.002).Thestudyby
Schulze et al. (16), which is the largest
andwhichusedrepeatedmeasuresofSSB
intake, reported the strongest study-
speciﬁc estimate. Removal of this study
from the pooled analysis reduced hetero-
geneity to borderline signiﬁcance (I
2 51%
[95% CI 0–78%]; P value, test for homo-
geneity 0.05). Tests for publication bias
generally rely on the assumption that
small studies (large variance) may be
more prone to publication bias, com-
pared with larger studies. Visual inspec-
tion of the Begg funnel plot
(supplementary Fig. 1A and B, available
in an online appendix at http://care.
diabetesjournals.org/cgi/content/full/dc10-
1079/DC1), whereby the SE of log RR
(measure of study size) from each study
was plotted against the log RR (treatment
effect), showed symmetry about the plot,
suggesting that publication bias is un-
likely, although values for metabolic
syndrome may not be particularly infor-
mative because of the small number of
studies included in the analysis. Studies
with a large SE and large effect may sug-
gest the presence of a small-study effect
(the tendency for smaller studies in a
meta-analysistoshowlargertreatmentef-
fects). Results from the Begg (type 2 dia-
betes P  0.75; metabolic syndrome P 
1.0) and Egger (type 2 diabetes P  0.75;
metabolic syndrome P  0.72) tests also
suggest that publication bias is unlikely.
Because the association between SSB
consumption and risk of these disease
outcomes is mediated in part by energy
intakeandadiposity,adjustmentforthese
factors will tend to underestimate any ef-
fect. Results from our sensitivity analysis
in which energy- and adiposity-adjusted
coefﬁcients were excluded (11,14,18)
showed a slight increase in risk of type 2
diabetes with a pooled RR of 1.28 (95%
CI 1.13–1.45) from the random-effects
model and RR 1.25 (1.18–1.34) from the
ﬁxed-effects model. A greater magnitude
of increase was noted in the dose-
response meta-analysis when these stud-
ies (11,14,18) were excluded: RR 1.35
(1.14–1.59) and RR 1.18 (1.12–1.24)
from the random and ﬁxed-effects mod-
els, respectively. However, results from a
meta-regression did not ﬁnd adjustment
for energy to be a signiﬁcant predictor of
effect (P  0.38). Sensitivity analysis was
not possible for studies of metabolic syn-
drome because they are too few in num-
ber; however, both studies that adjusted
for these potential mediators of effect had
marginal nonsigniﬁcant associations
(11,12), whereas the study that reported
unadjusted estimates showed a strong
positive association (13).
CONCLUSIONS— Findings from
our meta-analyses show a clear link be-
tween SSB consumption and risk of met-
abolic syndrome and type 2 diabetes.
Based on coefﬁcients from three prospec-
tive cohort studies including 19,431 par-
ticipants and 5,803 cases of metabolic
syndrome, participants in the highest cat-
egory of intake had a 20% greater risk of
developing metabolic syndrome than
those in the lowest category of intake. For
type 2 diabetes, based on data from eight
prospective cohort studies (nine data
points), including 310,819 participants
and 15,043 cases of type 2 diabetes, par-
ticipants in the highest category of SSB
intake had a 26% greater risk of develop-
ing type 2 diabetes than participants in
the lowest category of intake.
Because we compared extreme quan-
tilesofSSBintake,mostoftennoneor1
serving/monthwith1or2servings/day,
categories of intake between studies were
not standardized. Therefore, it is possible
that random misclassiﬁcation somewhat
attenuated the pooled estimate; however,
results were similar to the dose-response
analysis, which used data from all catego-
ries. For those studies that did not deﬁne
serving size, a standard serving of 12 oz
was assumed, which may over- or under-
estimate empirical SSB intake levels but
should not materially affect our results.
Indeed there is substantial variation in
study design and exposure assessment,
across studies, which may explain the
large degree of between-study heteroge-
neity we observed. Meta-analyses are in-
herently less robust than individual
prospective cohort studies but are useful
in providing an overall effect size, while
giving larger studies and studies with less
random variation greater weight than
smaller studies. Publication bias is always
a potential concern in meta-analyses, but
standard tests and visual inspection of
funnel plots suggested no evidence of
publication bias in our analysis. Ascer-
tainmentofunpublishedresultsmayhave
reduced the likelihood of publication
bias. Because our analysis compared only
thetopwiththebottomcategories,wedid
not use data from the intermediate cate-
gories. Thus, the comparison of extreme
categories was not statistically signiﬁcant
for the studies of Montonen et al. (14),
Paynter et al. (women) (15), and Bazzano
et al. (18), even though the overall tests
for trend in these studies were signiﬁcant.
All studies included in our meta-
analysisconsideredadjustmentforpoten-
tial confounding by various diet and
lifestyle factors, and for most a positive
association persisted, suggesting an inde-
pendent effect of SSBs. However, residual
confounding by unmeasured or imper-
fectly measured factors cannot be ruled
out.HigherlevelsofSSBintakecouldbea
marker of an overall unhealthy diet as
they tend to cluster with factors such as
higher intakes of saturated and trans fat
and lower intake of ﬁber (12). Therefore,
incomplete adjustment for various diet
and lifestyle factors could overestimate
thestrengthofthepositiveassociationbe-
tween SSB intake and risk of metabolic
syndrome and type 2 diabetes. However,
consistency of results from different co-
horts reduces the likelihood that residual
confounding is responsible for the ﬁnd-
ings. Longitudinal studies evaluating diet
and chronic disease risk may also be
prone to reverse causation, i.e., individu-
alschangetheirdietbecauseofsymptoms
of subclinical disease or related weight
gain, which could result in spurious asso-
ciations (24). Although it is not possible
Malik and Associates
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studies with longer durations of fol-
low-up and repeated measures of dietary
intake tend to be less prone to this
process.
Inseveralstudies,type2diabeteswas
assessed by self-report; however, it has
beenshowninvalidationstudiesthatself-
reportoftype2diabetesishighlyaccurate
according to medical record review (25).
The majority of studies used validated
FFQs to measure SSB intake, which is the
most robust method for estimating an in-
dividual’s average dietary intake com-
pared with other assessment methods
such as 24-h diet recalls (26). However,
measurement error in dietary assessment
is inevitable, but because the studies we
consideredareprospectiveindesign,mis-
classiﬁcation of SSB intake probably does
not differ by case status. Such nondiffer-
ential misclassiﬁcation of exposure is
likely to underestimate the true associa-
tion between SSB intake and risk of these
outcomes.
SSBs are thought to lead to weight
gain by virtue of their high added sugar
content, low satiety potential and incom-
plete compensatory reduction in energy
intake at subsequent meals after con-
sumption of liquid calories, leading to
positive energy balance (7,8). Although
SSBs increase risk of metabolic syndrome
and type 2 diabetes, in part because of
their contribution to weight gain, an in-
dependent effect may also stem from the
highlevelsofrapidlyabsorbablecarbohy-
drates in the form of added sugars, which
are used to ﬂavor these beverages. The
ﬁndings by Schulze et al. (16) suggested
that approximately half of the effects of
SSBs on type 2 diabetes were mediated
through obesity. In a recent study among
88,000 women followed for 24 years,
those who consumed 2 SSBs/day had a
35%greaterriskofcoronaryheartdisease
compared with infrequent consumers af-
ter adjustment for other unhealthy life-
style factors (RR 1.35 [95% CI 1.1–1.7,
Ptrend  0.01) (27). Additional adjust-
ment for potential mediating factors in-
cluding BMI, total energy, and incident
type 2 diabetes attenuated the associa-
tions, but they remained statistically sig-
niﬁcant, suggesting that the effect of SSBs
is not entirely mediated by these factors.
Because SSBs have been shown to
raise blood glucose and insulin concen-
trationsrapidlyanddramatically(28)and
are often consumed in large amounts,
they contribute to a high dietary glycemic
load. High glycemic load diets are known
to induce glucose intolerance and insulin
resistance particularly among overweight
individuals (9) and can increase levels of
inﬂammatory biomarkers such as C-reac-
tive protein, which are linked to type 2
diabetes risk (29). Findings from our co-
hortsindicatethatahighdietaryglycemic
loadalsoincreasesriskofdevelopingcho-
lesterol gallstone disease, which is associ-
ated with insulin resistance, metabolic
syndrome, and type 2 diabetes (30). En-
dogenous compounds in SSBs, such as
advanced glycation end products, pro-
duced during the process of carameliza-
tionincola-typebeveragesmayalsoaffect
pathophysiological pathways related to
type 2 diabetes and metabolic syndrome
(31). SSBs may also increase risk indi-
rectly by inducing alterations in taste
preferences and diet quality, resulting
from habitual consumption of highly
sweetenedbeverages,whichhasalsobeen
noted for artiﬁcially sweetened beverages
(5).
Short-term experimental studies sug-
gest that fructose, which is a constituent
of both sucrose and high-fructose corn
syrup in relatively equal parts, may exert
particularly adverse metabolic effects
compared with glucose. Fructose is pref-
erentiallymetabolizedtolipidintheliver,
leadingtoincreasedhepaticdenovolipo-
genesis, the development of high triglyc-
erides, low HDL cholesterol, small, dense
LDL, atherogenic dyslipidemia, and insu-
lin resistance (32). Recent evidence has
also shown that fructose consumption
maypromoteaccumulationofvisceralad-
iposity or ectopic fat deposition (10), two
key features of a dysmetabolic state in-
creasing risk of type 2 diabetes and car-
diovascular disease (33), despite no
differenceinweightgainbetweenglucose
and fructose conditions (10). In contrast,
some studies have shown greater satiety
and lower total energy intake after intake
of fructose-containing beverages com-
pared with glucose beverages (34). Gha-
nim et al. (35) found evidence of
oxidative and inﬂammatory stress after
intake of glucose but not fructose or or-
ange juice. However, fructose has also
been shown to increase blood pressure
when administered acutely or when con-
sumed as SSBs, an effect not observed
with glucose administration or consump-
tion of aspartame-sweetened beverages
(36,37). A number of prospective cohort
studies have found positive associations
between SSB consumption and incident
hypertension (11,13). Fructose is also the
onlysugarabletoincreaseblooduricacid
concentrations, and SSB consumption
has been linked to development of hyper-
uricemia (serum uric acid level7 mg/dl
for men and 5.7 mg/dl for women) (38)
and gout (39). Men who consumed 2
SSBs/day had an 85% greater risk of de-
veloping gout compared with infrequent
consumers(RR1.85[95%CI1.08–3.16];
Ptrend  0.001 for trend). No association
was shown with diet soda. A recent ran-
domized controlled trial among men in
Spain showed that high doses of fructose
increased blood pressure and induced
features of metabolic syndrome and that
pharmacologically lowering uric acid lev-
elspreventedtheincreaseinmeanarterial
blood pressure (40).
In summary, this meta-analysis has
demonstratedthathigherconsumptionof
SSBs is signiﬁcantly associated with de-
velopment of metabolic syndrome and
type 2 diabetes. It provides further sup-
port to limit consumption of these bever-
ages in place of healthy alternatives such
aswatertoreduceobesity-relatedchronic
disease risk.
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